本季度信息
截至2025年6月30日止财年，盈健医疗集团收入约6.44亿港元，同比增长9.1%；经调整净利润约2,634万港元，同比增幅8.9%。本财年毛利率从上年的45.7%小幅提升至45.8%。经营端，提供服务成本同比增长8.7%，行政及其他开支同比增长2.9%。经营活动产生的现金流量大幅增至约9,860万港元，上一财年同期为约1,320万港元。
成本结构方面，本期销售及管理等综合费用率较为稳定，研发投入数据未在报告中披露。
业务分项
全科医疗服务收入约4.11亿港元，同比增长3.1%。专科医疗服务收入约1.66亿港元，同比增长23.8%。牙科服务收入约6,776万港元，同比增长15.9%。其中，牙科板块的毛利率继续提升至42.9%，上年同期为41.4%。
高管解读
董事会主席兼行政总裁陈健平先生表示：“在全球宏观经济环境变动以及消费动态转换的背景下，本集团韧性依旧，收入与利润均录得显著增长。我们将持续强化核心医疗服务的布局，并在牙科与专科业务等领域寻找增量机会，维持对社区健康的承诺。”
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.